Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Part of paid clinical trials in Boulder, Colorado.

Sponsor
HemoCept Inc.
Study ID
NCT07224906
Status
Recruiting
Apply to this trial

Conditions

  • Congestive Heart Failure(CHF)
  • Pulmonary Hypertension
  • Valve Disease, Heart

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.

Key Dates

Start date
Dec 1, 2025
Status verified
Apr 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Association between device measurements and Pulmonary Capillary Wedge Pressure [ Time Frame: Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Boulder HeartBoulderColorado80303
Katharine Adkins
[email protected]
303-442-2395
Scott Blois, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boulder, CO

By research site
Boulder Heart· Boulder, CO

Related Studies